You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

2,4-thiazolidinedione

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Philadelphia (Palbociclib, Tazemetostat,

Not yet recruiting
  • Recurrent Acute Myeloid Leukemia
  • Refractory Acute Myeloid Leukemia
  • Philadelphia, Pennsylvania
    Thomas Jefferson University Hospital
Jan 13, 2023

Localized Osteosarcoma, Metastatic Osteosarcoma, Resectable Osteosarcoma Trial (Bone Scan, Cabozantinib S-malate, Cisplatin)

Not yet recruiting
  • Localized Osteosarcoma
  • +3 more
  • Cabozantinib S-malate
  • +7 more
  • (no location specified)
Jan 4, 2023

NAFLD, Obesity, Type 2 Diabetes Trial (Saroglitazar)

Not yet recruiting
  • NAFLD
  • +4 more
  • (no location specified)
May 25, 2023

Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial (Biospecimen Collection, Letermovir)

Not yet recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Malignant Solid Neoplasm
  • (no location specified)
Jan 23, 2023

HR+/HER2-breast Cancer Trial (Standard endocrine therapy plus Apatinib)

Not yet recruiting
  • HR+/HER2-breast Cancer
  • Standard endocrine therapy plus Apatinib
  • (no location specified)
Jun 2, 2023

Pneumococcal Vaccines Trial in Canada (IVT PCV-25 Formulation A, IVT PCV-25 Formulation B, IVT PCV-25 Formulation C)

Not yet recruiting
  • Pneumococcal Vaccines
  • IVT PCV-25 Formulation A
  • +3 more
  • Vancouver, British Columbia, Canada
  • +3 more
Oct 10, 2023

Molar Incisor Hypomineralisation Trial in Latakia (Lidocaine 2%, Articaine 4%)

Recruiting
  • Molar Incisor Hypomineralisation
  • Lidocaine 2%
  • Articaine 4%
  • Latakia, Syrian Arab Republic
    Tishreen University
Dec 19, 2022

Papulopustular Rosacea Trial in Canada (Lotilaner Gel, 2.0%, Vehicle control gel)

Recruiting
  • Papulopustular Rosacea
  • Lotilaner Gel, 2.0%
  • Vehicle control gel
  • Oakville, Ontario, Canada
  • +4 more
Apr 20, 2023

Glucose Metabolism Disorders, Diabetes, Type 2, Hypoglycemic Agents Trial in Karachi (Empagliflozin 10 MG,

Recruiting
  • Glucose Metabolism Disorders
  • +3 more
  • Empagliflozin 10 MG
  • Insulin+Metformin+DPP4 inhibitor (DPP4I)
  • Karachi, Pakistan
    SINA Shireen Jinnah colony
Nov 28, 2023

Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Follicular Lymphoma, Recurrent Indolent Adult Non-Hodgkin Lymphoma Trial in

Suspended
  • Recurrent B-Cell Non-Hodgkin Lymphoma
  • +7 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Jan 20, 2023

Bipolar Disorder Trial in Canada (Cannabidiol, Placebo)

Not yet recruiting
  • Bipolar Disorder
  • Calgary, Alberta, Canada
  • +7 more
May 18, 2023

PLA2R-IgG4 Detection Kit

Enrolling by invitation
  • Membranous Nephropathy - PLA2R Induced
  • Kidney Diseases-except Membranous Nephropathy
    • Hangzhou, China
      ZhejiangBiostar
    May 6, 2023

    Analgesia Trial in Cairo (Ganglion Impar Neurolysis, Bilateral S2, S3 and S4 Pulsed radiofrequency)

    Recruiting
    • Analgesia
    • Ganglion Impar Neurolysis
    • Bilateral S2, S3 and S4 Pulsed radiofrequency
    • Cairo, Egypt
      Walaa Y Elsabeeny
    Jan 8, 2023

    COVID-19 Trial (Bivalent BNT162b2 (original/Omicron BA.4/BA.5) 3 microgram dose, Bivalent BNT162b2 (original/Omicron BA.4/BA.5)

    Not yet recruiting
    • COVID-19
    • Bivalent BNT162b2 (original/Omicron BA.4/BA.5) 3 microgram dose
    • +3 more
    • (no location specified)
    Dec 22, 2022

    A Scalp Lotion Toimprove Sensitive Scalp Syndrome

    Completed
    • Alopecia
    • Sensitive Skin
    • Piroctone Olamine (PO), 2,4 Diaminopyrimidine oxide (2.4 DA) and Vichy mineralizing water
    • Saint-Ouen, France
      L'OREAL Research and Innovation
    Nov 18, 2022

    Diabetes, Type 2 Trial in France (Use of the device DBL-4pen)

    Not yet recruiting
    • Diabetes Mellitus, Type 2
    • Use of the device DBL-4pen
    • Corbeil-Essonnes, France
    • +3 more
    Feb 8, 2023

    Lupus or SLE, Nephritis Trial in Assiut (Baricitinib 4 MG, Baricitinib 2 MG, MMF)

    Recruiting
    • Lupus or SLE
    • Nephritis
    • Baricitinib 4 MG
    • +2 more
    • Assiut, Yes, Egypt
      Manal Hassanien
    Jan 13, 2023

    Bietti's Crystalline Dystrophy Trial in China (ZVS101e)

    Recruiting
    • Bietti's Crystalline Dystrophy
    • Beijing, Beijing, China
    • +3 more
    Apr 16, 2023

    Facio-Scapulo-Humeral Dystrophy Trial (ARO-DUX4 for Injection, Placebo)

    Not yet recruiting
    • Facio-Scapulo-Humeral Dystrophy
    • ARO-DUX4 for Injection
    • Placebo
    • (no location specified)
    Nov 13, 2023

    Diabetic Macular Edema, Diabetic Retinopathy Trial (4D-150 IVT, Aflibercept IVT)

    Not yet recruiting
    • Diabetic Macular Edema
    • Diabetic Retinopathy
    • 4D-150 IVT
    • Aflibercept IVT
    • (no location specified)
    Jun 26, 2023

    Diabetes Trial in Nanjing (Duragtide, Semaglutide, losenatide, tirzepatide, ebenatide, etc)

    Recruiting
    • Diabetes
    • Duragtide, Semaglutide, losenatide, tirzepatide, ebenatide, etc
    • Nanjing, China
      Nanjing First Hospital, Nanjing Medical Univesity
    Aug 6, 2023

    Adults With Severe Eosinophilic Asthma on Benralizumab.

    Active, not recruiting
    • Severe Eosinophilic Asthma
    • Survey Administration
    • Calgary, Alberta, Canada
    • +19 more
    Dec 1, 2022

    Atopic Dermatitis Trial in Canada, United States (OpSCF, Placebo, OpSCF (Open Label Extension))

    Not yet recruiting
    • Atopic Dermatitis
    • OpSCF
    • +2 more
    • Birmingham, Alabama
    • +15 more
    Oct 25, 2023

    Non-melanoma Skin Cancer, Carcinoma, Squamous Cell, Carcinoma, Basal Cell Trial in Canada (Nicotinamide, Placebo)

    Not yet recruiting
    • Non-melanoma Skin Cancer
    • +3 more
    • Calgary, Alberta, Canada
    • +7 more
    Jul 13, 2023

    Locally Advanced Nasopharyngeal Carcinoma Trial in Guangzhou (2 cycles induction chemo, 3 cycles induction chemo)

    Recruiting
    • Locally Advanced Nasopharyngeal Carcinoma
    • 2 cycles induction chemotherapy
    • 3 cycles induction chemotherapy
    • Guangzhou, Other (Non U.s.), China
      First Affiliated Hospital, Sun Yat-Sen University
    May 6, 2023